GenBody COVID-19 Rapid Test Kit 25 Tests Vietnam

High accuracy: Sensitivity ~91 % and specificity ~100 % in clinical studies using nasopharyngeal swabs. For anterior nasal samples within 6 days of symptom onset: sensitivity ~92.3% and specificity ~99.04%. Flexible specimen type: Supports both anterior nasal and nasopharyngeal swabs, making sample collection easy and comfortable. Robust detection limits: LoD at 1.11 × 10² TCID₅₀/mL, with strong detection even for Omicron at Ct ≤ 25. All-inclusive kit (25 tests): 25 test cassettes, 25 swabs, 25 extraction tubes with buffer + filter caps. Dropper tips, tube holder, paper/plastic tray, controls, and instructions. CLIA-waived & professional use: For use in clinical settings under CLIA Waiver, Compliance, or Accreditation. Wide regulatory coverage: Marketed and distributed globally (US, Europe, Asia, South America), also part of NIH RADx initiative.